2010
DOI: 10.1016/j.psychres.2009.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
112
0
5

Year Published

2011
2011
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 150 publications
(131 citation statements)
references
References 31 publications
4
112
0
5
Order By: Relevance
“…Respondents report about the past week using a Likert type scale from 1 (not at all) to 5 (extremely) and responses to the MASQ derived a 30-item described by Wardenaar et al (2010) Wardenaar et al, 2010;Watson et al, 1995a,b).…”
Section: Self-report Distress Assessmentsmentioning
confidence: 99%
“…Respondents report about the past week using a Likert type scale from 1 (not at all) to 5 (extremely) and responses to the MASQ derived a 30-item described by Wardenaar et al (2010) Wardenaar et al, 2010;Watson et al, 1995a,b).…”
Section: Self-report Distress Assessmentsmentioning
confidence: 99%
“…However, the anhedonia subscale only consists of two items. Therefore, within the HAPPY study, the EDS has been extended with several anhedonia items depicted from the Dutch validated version of the MASQ (Mood and Anxiety Symptoms Questionnaire, originally developed by Watson and Clark in 1991 [74, 75]). Psychometric properties of this extended 14-item EDS-version will be tested in a subsample.…”
Section: Methodsmentioning
confidence: 99%
“…Following the proposed cut-off values, [18,36] the BAI total scores for each subtype were also clinically significant, with class 1 classifying as severe (>25), class 2 as moderate (16)(17)(18)(19)(20)(21)(22)(23)(24)(25), and class 3 as mild (8)(9)(10)(11)(12)(13)(14)(15).Comorbidity profiles also characterized classes 1 and 2, while showing that class 3 may represent a less severe clinical entity. Interestingly, the cognitive-autonomic subtype had the highest depressive comorbidity but the lowest use of antidepressants, for which we have no obvious explanation.…”
Section: Depression and Anxietymentioning
confidence: 99%
“…Comorbidity, that is, current comorbid affective disorders (major depressive disorder, social phobia, general anxiety disorder), number of suicide attempts, frequent use of antidepressants, benzodiazepine usage (at least 50% of the time), the WHODAS functioning score (World Health Organization Disability Assessment Schedule II) [23] as an overall disability index, the mastery scale score [24] indicating the extent to which a person perceives himself to be in control of events or situations, and the three subscale scores of the Mood and Anxiety Symptom Questionnaire-30, [25] with the negative affect subscale gauging emotional states such as fear, anger, or guilt; the positive affect subscale assessing moods such as feeling active, excited, delighted, enthusiastic, interested; and the somatic arousal subscale evaluating physiological arousal symptoms such as trembling, shaking, dizziness, sweating, and heart racing, having some overlap with BAI items.…”
Section: Validation and Description Of Identified Subtypesmentioning
confidence: 99%